446 related articles for article (PubMed ID: 16301993)
1. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA
Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
[TBL] [Abstract][Full Text] [Related]
5. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
[TBL] [Abstract][Full Text] [Related]
6. Cyclic phosphatidic acid inhibits RhoA-mediated autophosphorylation of FAK at Tyr-397 and subsequent tumor-cell invasion.
Mukai M; Iwasaki T; Tatsuta M; Togawa A; Nakamura H; Murakami-Murofushi K; Kobayashi S; Imamura F; Inoue M
Int J Oncol; 2003 Jun; 22(6):1247-56. PubMed ID: 12738990
[TBL] [Abstract][Full Text] [Related]
7. RNA interference reveals a differential role of FAK and Pyk2 in cell migration, leading edge formation and increase in focal adhesions induced by LPA in intestinal epithelial cells.
Jiang X; Jacamo R; Zhukova E; Sinnett-Smith J; Rozengurt E
J Cell Physiol; 2006 Jun; 207(3):816-28. PubMed ID: 16508947
[TBL] [Abstract][Full Text] [Related]
8. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
[TBL] [Abstract][Full Text] [Related]
10. Sustained tyrosine-phosphorylation of FAK through Rho-dependent adhesion to fibronectin is essential for cancer cell migration.
Mukai M; Togawa A; Imamura F; Iwasaki T; Ayaki M; Mammoto T; Nakamura H; Tatsuta M; Inoue M
Anticancer Res; 2002; 22(6A):3175-84. PubMed ID: 12530062
[TBL] [Abstract][Full Text] [Related]
11. p85 beta-PIX is required for cell motility through phosphorylations of focal adhesion kinase and p38 MAP kinase.
Lee J; Jung ID; Chang WK; Park CG; Cho DY; Shin EY; Seo DW; Kim YK; Lee HW; Han JW; Lee HY
Exp Cell Res; 2005 Jul; 307(2):315-28. PubMed ID: 15893751
[TBL] [Abstract][Full Text] [Related]
12. FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts.
Iwanicki MP; Vomastek T; Tilghman RW; Martin KH; Banerjee J; Wedegaertner PB; Parsons JT
J Cell Sci; 2008 Mar; 121(Pt 6):895-905. PubMed ID: 18303050
[TBL] [Abstract][Full Text] [Related]
13. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
14. An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling.
Pirone DM; Liu WF; Ruiz SA; Gao L; Raghavan S; Lemmon CA; Romer LH; Chen CS
J Cell Biol; 2006 Jul; 174(2):277-88. PubMed ID: 16847103
[TBL] [Abstract][Full Text] [Related]
15. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y
Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043
[TBL] [Abstract][Full Text] [Related]
16. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
17. A role for the small molecular weight GTPases, Rho and Cdc42, in muscarinic receptor signaling to focal adhesion kinase.
Linseman DA; Hofmann F; Fisher SK
J Neurochem; 2000 May; 74(5):2010-20. PubMed ID: 10800944
[TBL] [Abstract][Full Text] [Related]
18. Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase.
Imamura F; Mukai M; Ayaki M; Akedo H
Jpn J Cancer Res; 2000 Aug; 91(8):811-6. PubMed ID: 10965022
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation is involved in reorganization of the actin cytoskeleton in response to serum or LPA stimulation.
Chrzanowska-Wodnicka M; Burridge K
J Cell Sci; 1994 Dec; 107 ( Pt 12)():3643-54. PubMed ID: 7706413
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A inhibits lysophosphatidic acid-induced migration of airway smooth muscle cells.
Hirakawa M; Karashima Y; Watanabe M; Kimura C; Ito Y; Oike M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1102-8. PubMed ID: 17347321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
